Neoadjuvant chemotherapy plus intensity-modulated radiotherapy versus concurrent chemoradiotherapy plus adjuvant chemotherapy for the treatment of locoregionally advanced nasopharyngeal carcinoma: a retrospective controlled study

Table 1 Characteristics of the 240 patients with locoregionally advanced nasopharyngeal carcinoma (NPC)

Characteristic	NAC + IMRT [cases (%)]	CCRT + AC [cases (%)]	χ²	P
Total	117	123
Age (years)			0.199	0.656
<50	83 (70.9)	84 (68.3)
≥50	34 (29.1)	39 (31.7)
Gender			1.148	0.284
Male	89 (76.1)	86 (69.9)
Female	28 (23.9)	37 (30.1)
T stage			1.029	0.794
T1	4 (3.4)	4 (3.3)
T2	11 (9.4)	14 (11.4)
T3	57 (48.7)	65 (52.8)
T4	45 (38.5)	40 (32.5)
N stage			3.578	0.311
N0	22 (18.8)	27 (22.0)
N1	40 (34.2)	50 (40.6)
N2	46 (39.3)	42 (34.1)
N3	9 (7.7)	4 (3.3)
Clinical stage			2.256	0.133
III	65 (55.6)	80 (65.0)
IV	52 (44.4)	43 (35.0)
WHO histology			0.313	0.576
II	13 (11.1)	11 (8.9)
III	104 (88.9)	112 (91.1)

NAC neoadjuvant chemotherapy, IMRT intensity-modulated radiotherapy, CCRT concurrent chemoradiotherapy, AC adjuvant chemotherapy, WHO World Health Organization

ISSN: 2523-3548